Jump to content

Money Order Still Not Cashed...

Recommended Posts

Hey guys! Sorry if this is in the wrong area but I’m a bit worried... LARA received my application and money order on Feb. 17, and it still hasn’t been cashed as of today (the 24th.) Is this unusual? Everything I’ve read says they want to cash it ASAP and usually do within 2-4 days of receiving. Anyone know what’s up? Thanks! 

Edited by ANFK88
Add tags

Share this post

Link to post
Share on other sites

I'm sure presidents day slowed down banking. Cashing the check is just banking. Doesn't matter and people put too much stress on the check or money order being cashed. 

You can prove they received your application so relax.

This might make you feel better; They cash the check or money order whether they approve you or not so the payment doesn't reflect what's going on with your application at all.

Share this post

Link to post
Share on other sites

I received my cert on December 5th, received my card January 11th.

I had holidays in there, so that delayed it.  You had a holiday, too, plus they've moved, so that may delay, too.

I know how you're feeling. Hoping to be THAT GUY who got his card earlier than most. :P

Don't stress.  Gven time and patience, it will come🤙

Edited by Phil69

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.


  • Similar Content

    • By compassionatesoul
      My friend just got notice that she will be battling cancer.  Shes not able to support herself financially and will need help down that road.  Can anyone steer her toward resources?  Traceys email...
      Thou art kind
    • By Michael Komorn
      After the MMMA was enacted by a vote of 63% of Michigan voters in 2008, the legislature has declined to add any new qualifying conditions to protect patients from arrest.
      Senator Rick Jones even attempted to remove Glaucoma from the MMMP's list of qualifying conditions. Patients , caregivers and other interested parties wrote in opposition to the bill.
      A handful of petitions have been submitted over the years. LARA (and the previous MDCH department) have used various reasons and tricks to deny these petitions. Only Post Traumatic Stress Disorder has been added as a qualifying condition to the Michigan Medical Marihuana Act. Autism and Parkinson's disorder petitions were approved by the Michigan medical marihuana review board (the board consists mostly of physicians). These petitions were denied by the LARA director. The petitions were not deficient in any way and should have been accepted by LARA. We resubmitted the Autism petition again, with 20 additional research studies.
      Now, with the help of numerous patients, researchers, Dwight Z. and Dr. Christian Bogner along with the Michigan Medical Marijuana Association and Michael Komorn, we have assembled a massive amount of peer-reviewed medical research and government data to show that these conditions should be approved to protect patients, caregivers and physicians from arrest for the medical use of marijuana to treat their conditions.
      This project took months of work. Reading, organizing, searching and collecting thousands of pages of research from all over the world. Including the most up to date medical studies, peer-reviewed patient surveys and the national reviews of all medical marijuana studies by the National Academies of Science. The oldest peer-reviewed medical research paper cited within these petitions was from the first volume of The Lancet in 1889. Birch EA. The use of Indian hemp in the treatment of chronic chloral and chronic opium poisoning. The Lancet. 1889;133:625.
      Cannabis, Indian Hemp, Marijuana, whatever you call it, physicians were using this non-toxic plant in 1889 to treat chronic opium poisoning and opium addiction. As opioid based prescriptions are addicting and killing approximately 142 Americans each day in 2017, medical marijuana is a non-lethal non-toxic way to avoid "America enduring a death toll equal to September 11th every three weeks."
      The qualifying condition petitions were based primarily on the following:
      Already approved qualifying conditions in other medical marijuana states. Historical and ancient medical books. Patient self-reports and surveys. US Government Department of Health and Human Services Patent on using marijuana to treat many diseases and injuries, including brain injury on humans. Institute of Medicine 1999 report on medical marijuana. This report was the basis for the MMMA, specifically cited within the Michigan law, MCL 333.26422 (b). National Academies of Science (formerly the Institute of Medicine) 2017 updated report on medical marijuana. Included research not only supports each qualifying condition petition, but also answers questions that the LARA directors, physicians and medical marijuana review panel board members had asked of past petitioners. Reports on dosages, safety profiles of marijuana, statistics from the CDC and Poison Control, and information from NIH, FDA and the DEA are presented in the petitions. This information was included in order to compare the safety, effects and side-effects of medical marijuana with FDA approved prescription medications.
      All of the patients, caregivers, researchers, the Michigan Medical Marijuana Association and it's president Michael Komorn fully agree that marijuana should be removed from the Controlled Substances Act. Marijuana should continue to be studied as a treatment for every human and animal disease. Marijuana also should be submitted to the FDA for approval as a medicine. We fully support all clinical trials related to using marijuana as a treatment for any condition, disease or injury. As all of the scientific peer-reviewed published clinical trials show, marijuana is an effective medicine.
      The http://www.nih.gov website was heavily utilized throughout this project for locating scientific peer-reviewed published research, reports and information.
      The petitions are grouped by similar conditions, symptoms or mechanisms of treatment. Included in this post are some choice quotes from a few studies in each group of petitions.
      Marijuana and Medicine Assessing the Science Base 1999 report from the Institute of Medicine

      Medical Cannabis in Arizona: Patient Characteristics, Perceptions, and Impressions of Medical Cannabis Legalization.
      Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) inthe treatment of pain caused by rheumatoid arthritis
      Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis


      Effects of smoked marijuana in experimentally induced asthma.
      Effects of cannabis on lung function: a population-based cohort study
      Newspaper ad from 1876 selling marijuana cigarettes for treating asthma.

      You may laugh at a marijuana cigarette as a real medical treatment, but marijuana is a verified bronchodilator similar in strength to albuterol, the standard asthma medication. The medical efficacy of this specific brand of Asthma cigarettes were specifically exempted within the Single Convention on Narcotic Drugs as created by the United Nations. This means these marijuana cigarettes were still able to be sold after each country banned marijuana.
      The Health Effects of Cannabis and Cannabinoids The Current State of Evidence and Recommendations for Research (2017)
      The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults
      Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
      Minnesota Medical Cannabis Program: Patient Experiences from the First Program Year by the MN Department of Health 2016.
      Cannabinoids and the Urinary Bladder
      Cannabinoids and gastrointestinal motility: Animal and human studies
      Medical cannabis – the Canadian perspective
      Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.

      Medical Marijuana and Organ Transplantation: Drug of Abuse, or Medical Necessity?

      LARA statistics show the majority of the 250,000+ patients in the MMMA are using cannabis to treat chronic pain. As we know that the medical use of marijuana can treat “severe and chronic pain” already, it can and should be used to treat regular generic pain that is not severe and chronic.
      The reports and information from the Minnesota Department of Health on its medical marijuana program are very detailed and informative about patients experiences with medical marijuana.
      Minnesota Medical Cannabis Program: Patient Experiences from the First Program Year by the MN Department of Health 2016.
      Other states already approve of medical marijuana for Parkinson's Disease.
      Including: Georgia, Vermont, Connecticut, Florida, Illinois, Massachusetts, New Hampshire, Ohio, New Mexico, New York, Pennsylvania, West Virginia and California

      Tourette’s Syndrome is an approved medical marijuana qualifying condition in Arkansas, Illinois, Minnesota and Ohio. While the MMMA covers persistant and severe Muscle Spasms, Tourette's Syndrome sufferers may not have the severe symptoms that qualify.
      The 1999 Institute of Medicine report states that marijuana can be used to treat Tourettes

      Pennsylvania Medical Marijuana Program lists Autism as a qualifying condition.
      There are two clinical trials for Autism and cannabis in 2017:
      Cannabinoids for Behavioral Problems in Autism Spectrum Disorder: A Double Blind, Randomized, Placebo-controlled Trial With Crossover.
      Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)
      Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study.
      An Open Label Study of the Use of Dronabinol (Marinol) in the Management of Treatment-Resistant Self-Injurious Behavior in 10 Retarded Adolescent Patients
    • By Wiilam
      How do I veiw pics that are on posted comments?
    • By Michael Komorn
      Effective Monday, February 26, 2018. the Bureau of Medical Marihuana Regulation will begin operating at its new location at2407 North Grand River, Lansing, Michigan.  Applications for a state operating license for a marihuana facility will no longer be accepted at 611 West Ottawa Street. Those applications and payments for application fees and regulatory assessments will be accepted at the new location between the hours of 8 a.m. and 5 p.m., Monday through Friday.  To allow time for processing, please arrive no later than 4:30 p.m.
      Applications for the medical marihuana program will not be accepted on-site.  Individuals should follow the instructions provided on the application for registry identification card and mail the completed form, required supporting documentation, and fee (if applicable) to the address provided on the form.
      LARA is an equal opportunity employer/program.  
      Auxiliary aids, services and other reasonable accommodations are available upon request to individuals with disabilities. 
      For more information about LARA, please visit www.michigan.gov/medicalmarihuana
      Follow us on Twitter www.twitter.com/michiganLARA
      “Like” us on Facebook or find us on YouTube www.youtube.com/michiganLARA
    • By Michael Komorn
      Next Friday, July 31 is a very important day for the Michigan Medical Marijuana community. The MMMA, along with physicians, lawyers, and families have worked tirelessly for more than a year to add autism as a qualifying condition under the Act, and next Friday is the vote to add or deny autism into the law.
      Please attend this vote, particularly if you treat your child with marijuana, to show solidarity with the parents of autistic children and family members that have led this drive. Komorn Law has pledged to compensate food and gas for all families with children that attend.
      Just attending the panel meeting can make a huge difference, there are many people with a debilitating condition who cannot make it. If you know someone in Lansing, ask them to attend. Friday is the ideal day to show respectful support that will have a real, meaningful impact on the panel's vote, and on the futures of these parents and children in need.
      I am sure all of you can understand how important this vote is for the families who have children afflicted with autism. I personally would like to believe that with all the hoopla and attention towards legalization lately the patients and families of patients are not lost or overlooked. Medical cannabis is the real deal. For the last 6 years we have all shared together in the miracles of this plant. We have danced on this forum together making history in Michigan as we implement the 2008 voter initiative. The battle continues and the fight is scheduled for July 31. Your appearance will be a strong showing of unity of our medical cannabis community. It will help provide evidence that medical cannabis is real, and safe access for those afflicted with autistism must be the next step for the MMMA.
  • Create New...